Search clinical trials for: MK0663, etoricoxib

Total 257 results

Organon and Co

Completed

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)

Coronary Disease | Hypercholesterolemia
Organon and Co

Completed

An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

Coronary Disease | Hypercholesterolemia
Organon and Co

Completed

Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)

Hypercholesterolemia
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)

Prostate Cancer
Organon and Co

Completed

Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

Coronary Disease | Hypercholesterolemia
Organon and Co

Completed

Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)

Lipid Metabolism Disorder
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Future University in Egypt

Completed

Bioequivalence Study of Etoricoxib in Healthy Adult Subjects Under Fasting Condition

Healthy Subjects

Egypt
Organon and Co

Completed

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

Coronary Disease | Hypercholesterolemia
Merck Sharp & Dohme LLC

Completed

A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer (0683-070)(COMPLETED)

Advanced Cancer Relapsed | Advanced Cancer Refractory
Organon and Co

Completed

Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070)

Hypercholesterolemia
Organon and Co

Completed

Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

Hypercholesterolemia | Hypertriglyceridemia
Fundación Lindavista del Corazón AC

Terminated

Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)

Hypertension
Organon and Co

Completed

Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)

Hypercholesterolemia
Organon and Co

Completed

Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)

Hypercholesterolemia
Organon and Co

Completed

Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

Hypercholesterolemia | Hypertriglyceridemia
Tel-Aviv Sourasky Medical Center

Unknown

Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery

Pain | Edema | Trismus
Organon and Co

Completed

MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)

Migraine Headache
Merck Sharp & Dohme LLC

Completed

A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED)

Type 2 Diabetes Mellitus
Organon and Co

Completed

An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)

Heart Disease | Lipid Metabolism, Inborn Errors
Merck Sharp & Dohme LLC

Completed

An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)

B-cell Lymphoma
Merck Sharp & Dohme LLC

Terminated

Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)

Diabetes Mellitus Type 2
Dow University of Health Sciences

Not yet recruiting

Comparison of the Anti-Inflammatory Efficacy of Preemptive Dexamethasone and Etoricoxib

Effect of Drug
Meir Medical Center

Completed

Etoricoxib Versus Gabapentin for Knee Arthroscopy

Knee Arthroscopy

Israel
Laboratorios Silanes S.A. de C.V.

Completed

Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain

Acute Low Back Pain

Mexico
Merck Sharp & Dohme LLC

Completed

Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)

Mycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma
Hillel Yaffe Medical Center

Unknown

Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer

Ovarian Cancer

Israel
Merck Sharp & Dohme LLC

Completed

A Study of Dalotuzumab (MK-0646) in Breast Cancer Patients (MK-0646-013)

Breast Cancer
University of Belgrade

Completed

Effect of Preemptive Etoricoxib and Dexamethasone on Wound Healing and Clinical Parameters After Third Molar Surgery

Surgical Wound | Post Operative Pain

Serbia
Merck Sharp & Dohme LLC

Terminated

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)

Diabetes Mellitus, Type 2
Muhammad Ilyas

Not yet recruiting

The Effect of Pregabalin and Etoricoxib on Pain Alone Versus in Combination

Back Pain Lower Back Chronic
Organon and Co

Completed

A Study to Asses the Effect of MK0663 in the Treatment of Patients With Postoperative Dental Pain (0663-092)

Postoperative Dental Pain
Dexa Medica Group
PT. Equilab International

Completed

Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets

Healthy

Indonesia
Merck Sharp & Dohme LLC

Completed

Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1))

Multiple Myeloma
Merck Sharp & Dohme LLC

Terminated

A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)

Carcinoma, Non-Small-Cell Lung
University of Regensburg
ClinAssess GmbH

Unknown

Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma

Advanced Melanoma

Germany
Rambam Health Care Campus

Completed

Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

Knee, Osteoarthritis (OA) | Biomarkers for Prediction of OA Treatment Efficacy

Israel
Merck Sharp & Dohme LLC

Terminated

A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004)

Multiple Myeloma
Asker & Baerum Hospital

Completed

COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined

Rupture of Anterior Cruciate Ligament

Norway
Merck Sharp & Dohme LLC

Terminated

MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)

Metabolic X Syndrome Dyslipidemia
Organon and Co

Completed

Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)

Dysmenorrhea
Oslo University Hospital

Completed

Rebound Pain After Operations for Distal Radius Fractures With a Volar Plate in Brachial Plexus Block

Pain, Postoperative | Brachial Plexus Block

Norway
Novartis Pharmaceuticals

Completed

Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer (INV342)

Prostate Cancer

Germany
Organon and Co

Completed

A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)

Hypercholerolemia
Tatyasaheb Kore Dental College

Completed

EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).

Periodontitis | Saliva | Cyclooxygenase Two Inhibitors | Etoricoxib | Superoxide Dismutase

India
X-pert Med GmbH

Completed

Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric Exercise

Muscle Pain

Germany
Singapore General Hospital
Merck Sharp & Dohme LLC

Completed

Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty

Knee Osteoarthritis

Singapore
Spanish Foundation of Rheumatology

Completed

Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs

Ankylosing Spondylitis

Spain
University of Regensburg
Merck Sharp & Dohme LLC

Completed

Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty

Coxarthrosis | Arthroplasties Hip Replacement | Perioperative Blood Loss

Germany
Barbro Dahlen
Karolinska Institutet

Completed

COX-2 Inhibition in Allergic Asthma

Asthma

Sweden

3

Subscribe